UYM vs. CURE
UYM (ProShares Ultra Basic Materials) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds - UYM tracks the Dow Jones U.S. Basic Materials Index (200%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, UYM returned 12.48%/yr vs 13.49%/yr for CURE. A 0.56 correlation means they provide meaningful diversification when combined. UYM charges 0.95%/yr vs 1.08%/yr for CURE.
Performance
UYM vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UYM achieves a 27.95% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, UYM has underperformed CURE with an annualized return of 12.48%, while CURE has yielded a comparatively higher 13.49% annualized return.
UYM
- 1D
- 3.74%
- 1M
- 1.10%
- YTD
- 27.95%
- 6M
- 30.38%
- 1Y
- 36.06%
- 3Y*
- 11.85%
- 5Y*
- 4.60%
- 10Y*
- 12.48%
CURE
- 1D
- -0.55%
- 1M
- 13.71%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 28.51%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
UYM vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UYM ProShares Ultra Basic Materials | 27.95% | 9.46% | -8.00% | 17.47% | -23.10% | 54.58% | 16.56% | 35.09% | -35.68% | 51.51% |
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between UYM and CURE is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.54 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.56 |
The correlation between UYM and CURE shifts across timeframes, from 0.44 (1 year) to 0.56 (all time), reflecting how their relationship changes across market environments.
UYM vs. CURE - Sectors Allocation Comparison
Sectors
UYM
CURE
Basic Materials
-
Consumer Cyclical
-
Industrials
-
Communication Services
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Healthcare
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Basic Materials
UYM
CURE
-
Consumer Cyclical
UYM
CURE
-
Industrials
UYM
CURE
-
Communication Services
UYM
-
CURE
-
Consumer Defensive
UYM
-
CURE
-
Energy
UYM
-
CURE
-
Financial Services
UYM
-
CURE
-
Healthcare
UYM
-
CURE
Real Estate
UYM
-
CURE
-
Technology
UYM
-
CURE
-
Utilities
UYM
-
CURE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UYM vs. CURE — Risk / Return Rank
UYM
CURE
UYM vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Basic Materials (UYM) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UYM | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.34 | ||
| Sortino ratioReturn per unit of downside risk | +0.28 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.13 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.38 | 0.85 | +0.52 |
| Martin ratioReturn relative to average drawdown | 3.67 | 1.94 | +1.73 |
Loading charts...
Drawdowns
UYM vs. CURE - Drawdown Comparison
The maximum UYM drawdown since its inception was -92.77%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UYM and CURE.
Loading charts...
Drawdown Indicators
| UYM | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.77% | -69.19% | -23.58% |
Max Drawdown (1Y)Largest decline over 1 year | -23.85% | -31.10% | +7.25% |
Max Drawdown (3Y)Largest decline over 3 years | -43.88% | -51.93% | +8.05% |
Max Drawdown (5Y)Largest decline over 5 years | -48.25% | -52.23% | +3.98% |
Max Drawdown (10Y)Largest decline over 10 years | -73.31% | -69.19% | -4.12% |
Current DrawdownCurrent decline from peak | -7.32% | -26.94% | +19.62% |
Average DrawdownAverage peak-to-trough decline | -42.06% | -18.16% | -23.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.95% | 13.71% | -4.76% |
Volatility
UYM vs. CURE - Volatility Comparison
ProShares Ultra Basic Materials (UYM) and Direxion Daily Healthcare Bull 3x Shares (CURE) have volatilities of 14.01% and 14.30%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UYM | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.01% | 14.30% | -0.29% |
Volatility (6M)Calculated over the trailing 6-month period | 27.29% | 30.87% | -3.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.09% | 44.32% | -9.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.49% | 43.84% | -4.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.86% | 49.59% | -6.73% |
UYM vs. CURE - Expense Ratio Comparison
UYM has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.
Dividends
UYM vs. CURE - Dividend Comparison
UYM's dividend yield for the trailing twelve months is around 1.19%, more than CURE's 1.16% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
UYM ProShares Ultra Basic Materials | 1.19% | 1.47% | 0.98% | 0.28% | 0.88% | 0.52% | 0.56% | 1.24% | 0.94% | 0.38% | 0.55% | 0.42% |
Frequently Asked Questions
UYM and CURE have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.30%) compared to UYM (14.01%). In terms of maximum drawdown, UYM dropped -92.77% vs CURE's -69.19%.
On 10-year performance, CURE leads with 13.49% vs 12.48% for UYM. On fees, UYM is cheaper at 0.95% per year. On volatility, UYM has been the lower-risk option at 14.01%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.49% return vs 12.48%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UYM is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.
UYM has the higher dividend yield at 1.19%, compared with 1.16% for CURE.
UYM tracks Dow Jones U.S. Basic Materials Index (200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UYM and 1.08% for CURE.
UYM currently has the higher Sharpe Ratio (0.94 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UYM and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer